Pirl William F
Department of Psychiatry, The Massachusetts General Hospital, Warren 1220, 55 Fruit Street, Boston, MA 02114, USA.
J Natl Cancer Inst Monogr. 2004(32):32-9. doi: 10.1093/jncimonographs/lgh026.
This evidence-based report reviews the empiric literature on depression in people with cancer with a focus on three areas: occurrence, assessment, and treatment. More than 350 studies were identified through searches of the English-language literature published between 1966 and September 2001. Reports of occurrence are limited to prevalence studies, and prevalence rates vary widely despite standardized assessments. Rates of major depressive disorder and depressive symptoms comorbid with cancer appear to be 10%-25%. Although multiple instruments are available for assessing depressive symptoms, a clinical interview using Diagnostic and Statistical Manual of Mental Disorders criteria is the standard to which assessments are compared. Some data exist for the efficacy of psychosocial and pharmacologic treatments for depression in this population. No randomized, controlled studies of alternative medicine interventions were identified.
这份循证报告回顾了关于癌症患者抑郁症的实证文献,重点关注三个领域:发生率、评估和治疗。通过检索1966年至2001年9月发表的英文文献,共识别出350多项研究。关于发生率的报告仅限于患病率研究,尽管评估标准统一,但患病率差异很大。与癌症共病的重度抑郁症和抑郁症状的发生率似乎为10%-25%。虽然有多种工具可用于评估抑郁症状,但使用《精神疾病诊断与统计手册》标准进行的临床访谈是评估的比较标准。关于该人群抑郁症的心理社会和药物治疗效果有一些数据。未识别出替代医学干预措施的随机对照研究。